Table 1 Distribution of the studied cases according to different parameters (n = 18)
No. (%) | |
|---|---|
Sex | |
Male | 13 (72.2%) |
Female | 5 (27.8%) |
Age (years) | |
< 15 | 9 (50.0%) |
≥ 15 | 9 (50.0%) |
Median (Min.–Max.) | 15.0 (1.0–18.0) |
Mean ± SD | 13.33 ± 5.10 |
1ry site | |
Femur | 3 (16.7%) |
Head and neck | 3 (16.7%) |
Humerus | 2 (11.1%) |
Fibula | 2 (11.1%) |
Urinary bladder | 2 (11.1%) |
Iliac bone | 2 (11.1%) |
Tibia | 2 (11.1%) |
Scapula | 1 (5.6%) |
Abdominal wall | 1 (5.6%) |
Histopathology | |
Osteosarcoma | 7 (38.9%) |
Ewing sarcoma | 5 (27.8%) |
Rhabdomyosarcoma | 4 (22.2%) |
Myeloid sarcoma | 1 (5.6%) |
Synovial sarcoma | 1 (5.6%) |
SUV1 | |
Median (Min.–Max.) | 6.0 (2.80–13.0) |
Mean ± SD | 6.71 ± 3.22 |
SUV2 | |
Median (Min.–Max.) | 2.30 (1.20–20.0) |
Mean ± SD | 4.86 ± 5.80 |
Histologic response | |
Good responder | 12 (66.7%) |
Poor responder | 6 (33.3%) |